TCR-T-EBV

N/A

Report date: 2025/11/17 10:28:54

Base Information

Drug NameTCR-T-EBV
Drug Alias NameTCR-T-EBV
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesImmunotech Applied Science Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunotech Applied Science Ltd
Inactive CompaniesN/A
Active IndicationsEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A